Aqueous extracts of Portulaca oleracea L. alleviate atopic dermatitis by restoring skin barrier function

Aqueous extracts of Portulaca oleracea L. alleviate atopic dermatitis by restoring skin barrier function

BackgroundPortulaca oleracea L. (PO) is an edible plant with a long medicinal history in traditional Chinese medicine for various inflammatory diseases, including skin disorders such as atopic dermatitis (AD). However, the anti-inflammatory effects and AD-alleviating mechanisms of PO remain unclear....

Full description

Saved in:

Bibliographic Details
Main Authors:	Haobin Wei, Zhang Chen, Wenjie Lai, Wenxian Wang, Xiqing Bian, Limin Zhang, Xinzhi Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Pharmacology
Subjects:	purslane aurantiamide acetate epidermal barrier cutaneous inflammation JAK1 inhibition filaggrin
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1591394/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Purslane—Portulaca oleracea L.
by: James M. Stephens
Published: (2025-07-01)

Atopic dermatitis, modern strategy in the therapy
by: V. A. Revyakina, et al.
Published: (2021-06-01)

Modern Treatment Options for Epidermal Dysfunction at Atopic Dermatitis
by: Eduard T. Ambarchyan, et al.
Published: (2023-11-01)

Filaggrin and Atopic Dermatitis: Clinical and Pathogenetic Parallels and Therapeutic Possibilities
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01)

Phytochemical screening, antioxidant, and antimicrobial analysis of Portulaca oleracea seeds with in-silico molecular docking insights
by: Khursheed Ahmad Sheikh, et al.
Published: (2025-09-01)

Effects of naphthalene, an aromatic hydrocarbon on the molecular and anatomical characteristics of the Portulaca oleracea plant
by: Zahra Janbazi, et al.
Published: (2025-07-01)

Atopic Dermatitis
by: D. Engler, et al.
Published: (2018-11-01)

Investıgatıon of the development of purslane plant (Portulaca Oleracea L.) under soil stress conditions
by: Elif Duyuşen Güven, et al.
Published: (2022-12-01)

Study of the effect of feeding two cultivars of purslane (Portulaca oleracea l.) On lipid profile and lipid peroxidation of adult male Sprague Dawley rats
by: Hasan Al-Amery, et al.
Published: (2020-10-01)

Wild grown Portulaca oleracea as a novel magnetite based carrier with in vitro antioxidant and cytotoxicity potential
by: Adina-Elena Segneanu, et al.
Published: (2025-03-01)

The role of structural skin proteins in the development of atopic dermatitis: A review
by: Julia A. Kandrashkina, et al.
Published: (2025-01-01)

Oleraceins from Portulaca oleracea leaves: Quali-quantitative determination and antioxidant potential
by: Ciro Cannavacciuolo, et al.
Published: (2025-01-01)

Filaggrin Defect at Atopic Dermatitis: Modern Treatment Options
by: Nikolay N. Murashkin, et al.
Published: (2022-11-01)

Portulaca oleracea L. (purslane) extract ameliorates intestinal inflammation in diet-induced obese mice by inhibiting the TLR4/NF-κB signaling pathway
by: Lingchao Miao, et al.
Published: (2025-01-01)

Clinical and hardware evaluation of moisturizing properties and tolerability of a emollient cream with filagrinol (“Admera”) in atopic dermatitis in children
by: S. S. Masalskiy, et al.
Published: (2023-07-01)

Lipophilic Extracts of <i>Portulaca oleracea</i> L.: Analysis of Bioactive Fatty Acids Targeting Microbial and Cancer Pathways
by: Dejan Stojković, et al.
Published: (2025-04-01)

Physicochemical Properties, Cooking and Sensory Qualities of Noodles Made from Wild Purslane (Portulaca oleracea L.) Seeds and Aerial Parts
by: Hatice Yel, et al.
Published: (2025-08-01)

Potential of Purslane (Portulaca oleracea L.) in Phytoremediation: A Study on the Bioaccumulation and Bio-Transfer of Cadmium, Nickel, and Copper in Contaminated Soils
by: Havva Aybike Erkoç, et al.
Published: (2024-03-01)

Portulaca oleracea (purslane) aqueous extract reduced the adverse metabolic outcomes and favored liraglutide activities in streptozotocin-induced cardiometabolic disorders of male Wistar rats
by: Adewumi O. Oyabambi, et al.
Published: (2024-09-01)

Possible causes, ways of development and stages of formation of atopic dermatitis in children
by: O.V. Gryn, et al.
Published: (2025-04-01)

The Effect of Grinding Techniques on the Microstructural Properties of Purslane (<i>Portulaca oleracea</i> L.) Powder, Its Total Phenolics Before and After In Vitro Simulated Gastrointestinal Digestion, and Its Antioxidant Capacity
by: Tea Bilušić, et al.
Published: (2025-07-01)

Restorative effects of camellia oil on the skin-barrier function in a model of DNCB-induced atopic dermatitis
by: Shicheng Jiao, et al.
Published: (2025-01-01)

Exploring Genetic Variants in Epidermal Differentiation Complex Genes in Severe Atopic Dermatitis: A Case Series
by: Lkhamdari Batbileg, et al.
Published: (2024-09-01)

The role of filaggrin mutations leading to a decrease in the amount of protein in the development of atopic dermatitis and bronchial asthma in children
by: S. I. Makarova, et al.
Published: (2021-06-01)

Targeted Filaggrin Gene (FLG) Sequencing: A Pilot Study among Indian Children with Atopic Dermatitis
by: Arun Somasundaram, et al.
Published: (2025-03-01)

Evaluation of the expression of <i>FLG, AHR</i> and <i>ARNT</i> genes in the skin of patients with atopic dermatitis after phototherapy
by: Irina V. Kozlova, et al.
Published: (2025-03-01)

Modern View on the Role of Epidermal Barrier in Atopic Phenotype Development in Children
by: Nikolay N. Murashkin, et al.
Published: (2020-01-01)

Complex therapy of atopic dermatitis: experience of using therapeutic cosmetics
by: E. E. Sidorenko, et al.
Published: (2024-12-01)

The Role of Minor Signs in Atopic Dermatitis Diagnostics
by: Olga B. Tamrazova, et al.
Published: (2020-08-01)

The epidermal lipid-microbiome loop and immunity: Important players in atopic dermatitis
by: Junchao Wu, et al.
Published: (2025-02-01)

New-onset psoriasis with abrocitinib therapy for atopic dermatitis
by: Sarah L. Becker, BA, et al.
Published: (2025-07-01)

THE ROLE OF EPIDERMAL BARRIER IMPAIRMENTS IN ATOPIC DERMATITIS: MODERN CONCEPTS OF DISEASE PATHOGENESIS
by: Nikolay N. Murashkin, et al.
Published: (2018-04-01)

Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry
by: Barbara Kind, et al.
Published: (2025-05-01)

A Chinese drug-compatibility-based approach to purslane hydrogels for acute eczema therapy
by: Ling Wang, et al.
Published: (2025-02-01)

Role of Emollients in Prevention of the Comorbid Allergic Diseases Development in Children with Atopic Dermatitis
by: Nikolay N. Murashkin, et al.
Published: (2020-09-01)

Mycosis fungoides unmasked by tralokinumab treatment for atopic dermatitis
by: Sanah Basrai, BA, et al.
Published: (2025-07-01)

Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
by: Sihan Wang, et al.
Published: (2025-01-01)

Biologic Therapy of Moderate and Severe Forms of Atopic Dermatitis in Children
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Exploring skin adverse events and mechanisms of apalutamide using data mining algorithms and network pharmacology
by: Yaqing Chen, et al.
Published: (2025-02-01)

Aggressive cutaneous squamous cell carcinoma in a patient on Janus-kinase inhibitor therapy
by: Ana M. Aragon Sierra, MD, et al.
Published: (2025-03-01)